推荐产品
品質等級
化驗
≥98% (HPLC)
形狀
solid
光學活性
[α]25/D −124.5°, c = 0.4 in H2O(lit.)
儲存條件
desiccated
顏色
white
溶解度
0.1 M HCl: 23 mg/mL
H2O: 7.3 mg/mL
儲存溫度
−20°C
SMILES 字串
Cl.[H][C@]12CCCN(CCC)[C@]1([H])Cc3c[nH]nc3C2
InChI
1S/C13H21N3.ClH/c1-2-5-16-6-3-4-10-7-12-11(8-13(10)16)9-14-15-12;/h9-10,13H,2-8H2,1H3,(H,14,15);1H/t10-,13-;/m1./s1
InChI 密鑰
HJHVRVJTYPKTHX-HTMVYDOJSA-N
基因資訊
human ... DRD2(1813) , DRD3(1814)
應用
(-)-喹吡罗盐酸盐在各种实验中作为选择性D2多巴胺(DA)受体激动剂。
生化/生理作用
喹吡罗是多巴胺激动剂,对D2 和D3多巴胺受体亚型具有高亲和力。大鼠脑中与特异性[3H]喹吡罗结合是可饱和的,具体结合情况取决于温度、膜浓度、钠浓度和鸟嘌呤核苷酸等因素。 推定D2 多巴胺受体激动剂喹吡罗(LY 171,555)是体内和体外研究中使用最广的D2激动剂。盐酸喹吡罗是(±)-喹吡罗的活性对映异构体。饱和分析显示,其具有高亲和力结合的特征(KD = 2.3 +/- 0.3 nM),可通过缔合-解离动力学得到证实。[3H]喹吡罗结合位点的区域分布与[3H]螺环哌啶酮结合位点的分布大致平行,在纹状体、伏隔核和嗅结节中密度最大。许多药物,主要是单胺氧化酶抑制剂(MAOl),抑制[3H]喹吡罗的结合,但不抑制[3H]螺环哌啶酮或[3H](-)N-n-丙基去甲阿朴吗啡的结合。在大鼠大鼠纹状体膜中,这一作用似乎由不涉及MAO酶活性的机制产生。临床上用于抗抑郁的 MAOI 显示出在[3H]喹吡罗标记和[3H]螺环哌啶酮标记的位点间具有选择性,一些结构相关的炔丙基胺、N-乙酰基乙二胺衍生物和其他药物(如异喹胍和苯基双胍)也是如此。MAOI 中的氯吉兰和 Ro 41-1049最为有效。MAOI 与新结合位点相互作用,这一位点由[3H]喹吡罗标记或调节[3H]喹吡罗结合。此位点可能与D2样多巴胺受体有关。
法律資訊
经美国礼来公司(Eli Lilly and Company)许可生产和销售。
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
個人防護裝備
Eyeshields, Gloves, type N95 (US)
其他客户在看
Role of ventral pallidal D2 dopamine receptors in the consolidation of spatial memory
Behavioural Brain Research, 313, 1-9 (2016)
Journal of neurochemistry, 123(3), 373-384 (2012-08-29)
In the CNS, an antagonistic interaction has been shown between adenosine A(2A) and dopamine D(2) receptors (A(2A)Rs and D(2)Rs) that may be relevant both in normal and pathological conditions (i.e., Parkinson's disease). Thus, the molecular determinants mediating this receptor-receptor interaction
Role of D2 dopamine receptors of the ventral pallidum in inhibitory avoidance learning
Behavioural Brain Research, 321, 99-105 (2017)
Neuropsychopharmacology reports, 41(3), 405-415 (2021-07-24)
A reduced mismatch negativity (MMN) response is a promising electrophysiological endophenotype of schizophrenia that reflects neurocognitive impairment. Dopamine dysfunction is associated with symptoms of schizophrenia. However, whether the dopamine system is involved in MMN impairment remains controversial. In this study
The international journal of neuropsychopharmacology, 25(7), 590-599 (2022-03-30)
The ventral pallidum (VP) is a dopaminoceptive forebrain structure regulating the ventral tegmental area (VTA) dopaminergic population activity. We have recently demonstrated that in the VP, the D2-like dopamine (DA) receptor agonist quinpirole dose dependently facilitates memory consolidation in inhibitory
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门